Noetik, an AI-native biotechnology company leveraging advanced machine learning and proprietary data to discover and develop precision cancer immunotherapies announces the appointment of Dr....
Iambic Therapeutics, a biotechnology company developing novel therapeutics using its unique AI-driven discovery platform, announced that the first patient has been dosed in its...
VRG50635 is one of the first clinical-stage drugs discovered and developed entirely using an AI-powered platform
Verge Genomics, a leading clinical-stage biotechnology company, and Ferrer,...
First-of-its-kind, fully integrated, AI-driven drug discovery and development platform will enable pharmaceutical R&D teams to generate therapeutics faster and more cost-effectively
1910 Genetics, the only...
Evaxion Biotech A/S, a clinical research-focused biotechnology company specializing in the development of vaccines powered by AI-Immunology™, announces the success of the initial phases...
Advances in AI Platform Provide an Ability to Rapidly Predict, Identify and Design Biomolecular Structures to Accelerate the Pace and Reduce the Cost of...
Investment underscores Aizon’s leadership position in AI-enhanced pharmaceutical manufacturing and will accelerate growth and launch of next-generation eBR
Aizon, an Artificial Intelligence (AI) SaaS provider...